Abstract
Vitamin D deficiency is a prominent feature of chronic kidney disease (CKD) even in its early stages. While vitamin D deficiency leads to mineral imbalance and bone problems in CDK patients, it also accelerates the progression of kidney disease. Ever since the observation that vitamin D analogs reduce proteinuria in CKD patients, it has been postulated that podocytes are major target of the reno-protective action of vitamin D. Recent large randomized clinical trials have confirmed the potent anti-proteinuric activity of vitamin D therapy. Studies from various animal models of kidney disease have demonstrated that vitamin D prevents podocyte injury and cell loss, promotes the expression of slit diaphragm proteins and maintains the integrity of the glomerular filtration barrier. Emerging experimental data suggest that vitamin D may protect podocytes by targeting multiple pathways, including the renin-angiotensin system, Wnt/β-catenin pathway and pro-apoptotic pathway.
Keywords: Vitamin D, Vitamin D analog, Podocyte, Diabetic nephropathy, Chronic kidney disease, 7-dehydrocholesterol, D 25-hydroxylase, 25-hydroxyvitamin, D3 (25OHD3), hydroxyvitamin D 1-hydroxylase (CYP27B1), parathyroid hormone, fibroblast growth factor (FGF), CYP24, rular filtration rate (GFR), DBP-25OHD3, receptor (VDR), PCNA, desmin, streptozotocin (STZ), actinin-4, losartan, Wnt/-catenin pathway, apoptotic pathway, hyper-glycemia, NF-B pathway, hyperreninemia, catenin, adriamycin injury, ameliorates podocyte lesio, p38, keratinocytes, Podocyte gene expression
Current Diabetes Reviews
Title: Podocytes as Target of Vitamin D
Volume: 7 Issue: 1
Author(s): Yan C. Li
Affiliation:
Keywords: Vitamin D, Vitamin D analog, Podocyte, Diabetic nephropathy, Chronic kidney disease, 7-dehydrocholesterol, D 25-hydroxylase, 25-hydroxyvitamin, D3 (25OHD3), hydroxyvitamin D 1-hydroxylase (CYP27B1), parathyroid hormone, fibroblast growth factor (FGF), CYP24, rular filtration rate (GFR), DBP-25OHD3, receptor (VDR), PCNA, desmin, streptozotocin (STZ), actinin-4, losartan, Wnt/-catenin pathway, apoptotic pathway, hyper-glycemia, NF-B pathway, hyperreninemia, catenin, adriamycin injury, ameliorates podocyte lesio, p38, keratinocytes, Podocyte gene expression
Abstract: Vitamin D deficiency is a prominent feature of chronic kidney disease (CKD) even in its early stages. While vitamin D deficiency leads to mineral imbalance and bone problems in CDK patients, it also accelerates the progression of kidney disease. Ever since the observation that vitamin D analogs reduce proteinuria in CKD patients, it has been postulated that podocytes are major target of the reno-protective action of vitamin D. Recent large randomized clinical trials have confirmed the potent anti-proteinuric activity of vitamin D therapy. Studies from various animal models of kidney disease have demonstrated that vitamin D prevents podocyte injury and cell loss, promotes the expression of slit diaphragm proteins and maintains the integrity of the glomerular filtration barrier. Emerging experimental data suggest that vitamin D may protect podocytes by targeting multiple pathways, including the renin-angiotensin system, Wnt/β-catenin pathway and pro-apoptotic pathway.
Export Options
About this article
Cite this article as:
C. Li Yan, Podocytes as Target of Vitamin D, Current Diabetes Reviews 2011; 7 (1) . https://dx.doi.org/10.2174/157339911794273964
DOI https://dx.doi.org/10.2174/157339911794273964 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cellular and Molecular Pathways that Lead to Progression and Regression of Renal Fibrogenesis
Current Molecular Medicine Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
Current Medicinal Chemistry Plant Terpenes on Treating Cardiovascular and Metabolic Disease: A Review
Protein & Peptide Letters Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery
Current Pharmaceutical Design Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Current Topics in Medicinal Chemistry Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases
Current Topics in Medicinal Chemistry Hypertension and Diabetes: Emphasis on the Renin – Angiotensin System and Insulin Resistance
Current Hypertension Reviews A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Mini-Reviews in Medicinal Chemistry Protective Effects of Incretin Against Age-Related Diseases
Current Drug Delivery Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Current Drug Safety Gas1 is a Pleiotropic Regulator of Cellular Functions: from Embryonic Development to Molecular Actions in Cancer Gene Therapy
Mini-Reviews in Medicinal Chemistry Natural Products as Anti-glycation Agents: Possible Therapeutic Potential for Diabetic Complications
Current Diabetes Reviews Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
Current Pharmaceutical Design The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Current Pharmaceutical Design Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
Current Pharmaceutical Design Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
Current Medicinal Chemistry Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice
Current Drug Metabolism Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design